I was diagnosed with intrahepatic cholestasis of pregnancy (IHCP) when I was 24 weeks pregnant. I then started taking medication for my liver enzymes. At 36 weeks, during my third trimester, my alkaline phosphatase level increased to 400. Can this affect my baby’s lung development? Is it possible for the baby’s two lungs to mature differently because of this?

Have a query?

Asked by Female, 34 · 23 days ago

Chandrakanta Jena

Pharm D

17 days ago

A rise in alkaline phosphatase in IHCP (a temporary liver condition that causes itching without a rash due to bile acid buildup in late pregnancy) is common and usually does not directly affect the baby’s lung development. Fetal lung maturity mainly depends on gestational age, and by 36 weeks, the lungs are generally well developed. It is very unlikely for the two lungs to mature differently because of this condition. However, close monitoring by your doctor is important to ensure your baby’s overall well-being.

Ask Apollo

AI powered Health Chatbot

⚕️ What this likely means

With IHCP (intrahepatic cholestasis of pregnancy) and an ALP (alkaline phosphatase) of 400 at 36 weeks, ALP alone is not a reliable indicator of fetal lung maturity; pregnancy commonly raises ALP because of placental isoenzymes.
The key maternal measure tied to fetal risk in IHCP is serum bile acids and full liver function tests (LFTs), not ALP by itself.

🫁 Effect on the baby’s lungs

Maternal cholestasis with very high bile acids can increase risks such as preterm birth and need for neonatal respiratory support, but it does not typically cause asymmetric maturity between the two lungs.
Fetal lung maturity is assessed by gestational age and specific tests (for example, amniotic fluid tests or clinical decisions about corticosteroids), not by maternal ALP.

⚕️ Most likely possibilities

ALP rise is pregnancy-related (placental origin).
ALP increase could reflect liver or bone contributions—needs correlation with other LFTs.
If bile acids are high, there is a higher chance of preterm delivery and neonatal respiratory issues (not unequal lung maturity).

🩺 Action steps

Ask your obstetrician or maternal–fetal medicine (MFM) specialist for recent serum bile acids and full LFTs and discuss implications.
Arrange fetal monitoring (nonstress test/ultrasound) as recommended.
If delivery before 37 weeks is considered, discuss antenatal corticosteroids for fetal lung maturation with your obstetrician/MFM.
Continue/adjust IHCP treatment only under specialist guidance.
Inform the neonatal team about IHCP before delivery.

⚠️ Warning signs (seek urgent care)

Marked decrease in fetal movements, severe itching (palms/soles), vaginal bleeding or regular contractions.

🩺 FOLLOW_UP

Do you have recent serum bile acid and full liver function test results?
Which medication are you currently taking for IHCP?

If you want, I can explain fetal lung tests or antenatal steroid options in more detail.

Answered 23 days ago

Welcome User